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Abstract
The revision of the Diagnostic and Statistical Manual of Mental Disorders (DSM) provides a useful opportunity to
revisit debates about the nature of psychiatric classification. An important debate concerns the involvement of
mental health consumers in revisions of the classification. One perspective argues that psychiatric classification is a
scientific process undertaken by scientific experts and that including consumers in the revision process is merely
pandering to political correctness. A contrasting perspective is that psychiatric classification is a process driven by a
range of different values and that the involvement of patients and patient advocates would enhance this process.
Here we draw on our experiences with input from the public during the deliberations of the Obsessive
Compulsive-Spectrum Disorders subworkgroup of DSM-5, to help make the argument that psychiatric classification
does require reasoned debate on a range of different facts and values, and that it is appropriate for scientist experts
to review their nosological recommendations in the light of rigorous consideration of patient experience and
feedback.
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Introduction
The current revision of the Diagnostic and Statistical
Manual of Mental Disorders (DSM) provides a useful
opportunity to revisit a broad range of debates about the
nature of psychiatric classification, and indeed of psych-
iatry. Some of the debate has understandably focused on
the extent to which advances in basic and clinical neuro-
science can and should inform revisions of the classifica-
tion [1,2]. There has perhaps been less debate on the
extent to which advances in public health constructs and
knowledge can and should inform such revisions [3].
In this paper, we want to consider a somewhat orthog-
onal set of considerations – namely, the question of who
should be included in deliberations about revisions of
the classification. There has been some debate about the
inclusion of different professional groups and individuals
from different locations, and it is gratifying to see the
substantial extent to which DSM-5 has been a multidiscip-
linary and multinational process [4]. There has perhaps
been less debate about the extent to which lay
perspectives should also be included, although the DSM-5
leadership has emphasized their importance [5].
We begin by outlining three contrasting approaches to
the debate about the inclusion of patient, consumer, cli-
ent, or health care user perspectives during the revision
of psychiatric diagnostic classifications. We then con-
sider the responses of the public to recommendations
put forth by the DSM-5 subworkgroup on Obsessive
Compulsive-Spectrum Disorders (which oversaw revi-
sions for the chapter of Obsessive-Compulsive and Re-
lated Disorders in DSM-5). We conclude by arguing that
it is important for scientific experts to review their noso-
logical recommendations in the light of rigorous consid-
eration of consumer experience and feedback.
Approaches to classification
For heuristic purposes, it is useful to outline a ‘classical’
approach to psychiatric classification. This approach is
based on particular philosophical positions on the nature
of science, the mind and language (for example, positiv-
ism), and the idea that diagnostic entities can be defined
by necessary and sufficient criteria [6,7]. The classical
approach sees diagnostic entities as similar to squares,
where the operational definition is invariant from time
to time, and place to place. This approach is consistent
* Correspondence: dan.stein@uct.ac.za
1Department of Psychiatry, University of Cape Town and Groote Schuur
Hospital J2, Anzio Rd, Observatory 7925, Cape Town, South Africa
Full list of author information is available at the end of the article
© 2013 Stein and Phillips; licensee BioMed Central Ltd. This is an Open Access article distributed under the terms of the
Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use,
distribution, and reproduction in any medium, provided the original work is properly cited.
Stein and Phillips BMC Medicine 2013, 11:133
http://www.biomedcentral.com/1741-7015/11/133
with the view that science is a process of obtaining data
from observations of the world and of developing laws
that describe the relationships between such data.
According to this view, the most relevant people to
consult when revising a diagnostic category are those
who are scientific experts in the relevant area. Scientific
experts are familiar with, or have generated, the relevant
data which speak to the optimal diagnostic criteria. Over
time, the diagnostic criteria more closely approximate
the true nature of the relevant entity. Increasingly, the
hope is stated that the diagnostic criteria will include
particular biomarkers [1].
For heuristic purposes, it is useful to also outline a
‘critical’ approach to psychiatric classification. This ap-
proach is based on philosophical positions on the nature
of science, the mind and language which contrast with
the classical ones (for example, hermeneuticism), and
the idea that psychiatric entities reflect the values of
classifiers [6,7]. The critical approach sees diagnostic en-
tities as similar to weeds, which are defined differently
by different classifiers from time to time and from place
to place. This approach is consistent with the view that
science, and particularly social science, is a social
process which involves participation in the world and an
understanding of human activities.
According to this view, the question of whom to in-
clude when revising a psychiatric classification is cru-
cially important. Different classifiers may bring to bear
different sets of expertise and different kinds of values.
It may, therefore, be relevant to include in the process
not only a range of professionals, but also those to
whom the classification will be applied. Terms such as
patients, clients, health care users, and consumers each
convey their own set of values, but for simplicity’s sake
we use ‘patients’ here.
An integrative perspective is a third approach, which
relies on philosophical constructs that draw on both the
classical and critical positions. This approach holds that
categories reflect both human practices as well as real
underlying structures and mechanisms. Weeds, for ex-
ample, are plants that are not wanted by gardeners, and
they also have typical characteristics (such as smothering
other plants). While psychiatric classification requires
the weighing of a range of facts and values, this can be
done in a reasonable way, so that advances in the nos-
ology are possible [6,7].
According to the integrative view, it is important to con-
sider a range of relevant facts and values when revising
the psychiatric nosology. Diagnostic entities should have
both clinical utility and diagnostic validity, and over time
we can develop categories with greater utility and validity.
While considerations about clinical utility and diagnostic
validity are ultimately weighed by scientific experts, this
weighing should include a rigorous knowledge and
understanding of patients’ experience. We consider the in-
tegrative perspective the most valuable, and we next draw
on experiences during the development of DSM-5 that re-
flect this view.
Getting input on obsessive-compulsive and related
disorders
The DSM-5 development process differed substantially
from the development of prior editions of DSM in a
number of ways. One of the most notable differences
was the extensive feedback that was solicited from the
public regarding proposed changes to DSM-IV. This ef-
fort was facilitated by the availability of the internet,
which was not yet widely available when DSM-IV was
developed during the early 1990s. Changes proposed for
DSM-5 by the various workgroups were posted three
times on the DSM-5 website in order to solicit input
from a broad range of individuals. The first posting
alone received nearly 40 million hits and more than
8,000 comments from professionals, consumers, and in-
terested individuals [5].
Our DSM-5 subworkgroup on Obsessive-Compulsive
Spectrum Disorders pondered a range of questions
about the optimal classification of these conditions. A
first question was whether DSM-5 should include a sep-
arate section on obsessive-compulsive and related disor-
ders. A second question was whether new entities such
as hoarding disorder and excoriation (skin picking) dis-
order, which were not included in prior editions of
DSM, should be included in this section. A third ques-
tion concerned whether some entities, such as trichotil-
lomania, should have a different name. A fourth
question concerned the optimal diagnostic criteria for
entities in this section.
Our subworkgroup reviewed the literature on obsessive-
compulsive and related disorders [8], and concluded that
there was sufficient scientific evidence to support the util-
ity and validity of this construct, which has been widely
adopted by the field for more than a decade. At the same
time, our review of the literature on anxiety disorders and
obsessive-compulsive disorder suggested that there was
considerable overlap between these sets of conditions [9].
The final recommendation of our subworkgroup was that
anxiety disorders and the new chapter of obsessive-
compulsive and related disorders should be placed next to
each other in the nomenclature in order to emphasize the
close relationship between some of the disorders in these
two chapters - for example, between body dysmorphic dis-
order and social anxiety disorder (social phobia) [10].
There was considerable feedback from the public, via
the internet postings, on this question. Patient advocates
for Tourette’s Disorder were concerned about the possi-
bility that Tourette’s Disorder would be classified in the
anxiety disorders’ chapter or the obsessive-compulsive
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and related disorders’ chapter. They argued that it was
important that Tourettte’s Disorder be seen as a
neurodevelopmental condition, and that it, therefore, fit
best into the new chapter of neurodevelopmental disor-
ders. Patient advocates for trichotillomania and skin
picking disorder were concerned that if these disorders
were classified alongside obsessive-compulsive disorder,
patients might receive inappropriate treatment.
In considering these viewpoints, our subworkgroup
noted that there were both overlaps and distinctions be-
tween OCD and a range of other putative obsessive-
compulsive and related disorders, and that this was the
case in other DSM-5 chapters as well. We also noted
that a tic specifier for obsessive-compulsive disorder was
important, as OCD patients with tics have particular
clinical characteristics, and that adding a tic specifier to
obsessive-compulsive disorder would emphasize the
clinically important relationship between tic disorders
and OCD [11]. Finally, our subworkgroup noted that it
would be important to use the DSM-5 text to emphasize
to readers how disorders in the chapters on obsessive-
compulsive and related disorders had both similarities
and differences.
Our subworkgroup reviewed the literature on hoarding
disorder and excoriation (skin picking) disorder [12,13]
and concluded that there was sufficient scientific evidence
to support the utility and validity of these diagnostic en-
tities. (We should note that all changes proposed by the
subworkgroup received extensive review by other DSM-5
committees to ensure that the proposed changes had ad-
equate scientific support, as changes for DSM-5 were
heavily based upon available scientific evidence.) There
was again considerable feedback from the public, includ-
ing members of the Trichotillomania Learning Center, on
these questions. In particular, hundreds of patients and
patient advocates commented that excoriation (skin pick-
ing) disorder and hoarding disorder should be included in
the nomenclature. Such feedback usefully complemented
available scientific data in emphasizing the clinical import-
ance and the clinical utility of these diagnostic entities.
Our subworkgroup carefully considered whether the
term ‘trichotillomania’, which was used in DSM-IV, was
an optimal name for this condition. We noted the con-
cerns of some patient advocates that ‘mania’ could be
perceived as pejorative and inaccurate. At the same time,
we noted the concerns of other patient advocates that
the alternative term ‘hair pulling disorder’, because of its
somewhat colloquial nature, could possibly detract from
the disorder’s medical significance. Our subworkgroup
also took into account the view that a change in name
could lead to confusion in the scientific literature. Our
subworkgroup, therefore, recommended a compromise
name: ‘trichotillomania (hair pulling disorder)’. A similar
set of considerations led to the choice of the term
‘excoriation (skin picking) disorder’. Our subworkgroup
considered the scientific literature on diagnostic criteria
for the various entities in the chapter on obsessive-
compulsive and related disorders. We noted, for ex-
ample, that the criteria for trichotillomania were based
on the notion that this was an impulse control disorder,
and that a sizeable minority of patients with distressing/
impairing and chronic hair-pulling did not demonstrate
all of the DSM-IV criteria. Comments on the website
strongly agreed with our subworkgroup’s recommendation
to change the problematic criteria; this change was also
supported by a study sponsored by the subworkgroup that
tested alternative criteria [14].
In summary, feedback from patients and patient advo-
cates played a useful role in influencing some of our
subworkgroup recommendations for the DSM-5 section
on obsessive-compulsive and related disorders. This
feedback complemented and, in some cases, reinforced
the value of recommendations that were based on the
scientific literature. Perhaps the most helpful impact of
this feedback was support from many individuals who
suffered from excoriation (skin picking) disorder to add
this condition to DSM-5; this input usefully supported
the view that the available scientific data were sufficient
to add this disorder to DSM-5. This feedback was also
helpful in assisting our subworkgroup with making rec-
ommendations for which no scientific data were avail-
able on which to base a recommendation (such as the
best name for trichotillomania).
Conclusion
Our view, consistent with the integrative position, is that
psychiatric classification requires reasoned debate on a
range of different facts and values, and that it is, there-
fore, appropriate for scientific experts to review their
evidence-based nosological recommendations in the
light of rigorous consideration of patient experience and
feedback. Given the complexity of defining psychiatric
disorders and their boundaries [15,16], any particular ap-
proach to the nosology has both pros and cons [17], and
reaching an optimal solution is enhanced by carefully
considering a broad range of perspectives [18], including
the views of patients and patient advocates [19].
It is notable that previous authorities have differed
considerably about the importance of including patients
in the process of revising psychiatric classifications
[20,21]. Such disagreement perhaps reflects differences
on which values to emphasize during the process of clas-
sification revision [22,23]. Nevertheless, it does appear
that there is growing consensus among nosologists, cli-
nicians, and researchers that psychiatric diagnosis and
treatment is necessarily dependent on first-person ac-
counts of subjective experience [24-26], that understand-
ing and appreciating individual voices and variations is
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crucial [27], and that it is important to include people
with or in recovery from mental illness as collaborators
in clinical and research processes [28].
That said, there is a dearth of data on questions such
as whether patient involvement in developing healthcare
policy and research, clinical practice guidelines and pa-
tient information material is, in fact, helpful, and rigor-
ous study of such involvement is needed [29]. Similarly,
while different models of patient involvement in nos-
ology have been proposed and developed [30], much
additional work is needed to compare carefully such
models and their impacts. Furthermore, it needs to be
kept in mind that even if a diagnostic system incorpo-
rates patient perspectives, assessment and intervention
should proceed with appropriate care in order to dimin-
ish stigma [31,32].
Our hope is that the addition of a chapter on obsessive-
compulsive and related disorders, including hoarding
disorder and excoriation (skin picking) disorder, has more
pros than cons and will be useful for individuals living
with these conditions, and for their care. The DSM-5
development process had very rigorous guidelines and cri-
teria for adding new disorders to DSM-5; enough scientific
evidence was available on both conditions to support their
addition to DSM-5. However, the input of patients and
patient advocates usefully highlighted and supported
the clinical importance of adding these disorders to the
nomenclature.
Our hope also is that the diagnostic criteria for these
entities, and all of those in the chapter of obsessive-
compulsive and related disorders, are as optimal as pos-
sible. Many patients and patient advocates were supportive
of the changes that we proposed and that were ultimately
accepted during the extensive review process of workgroup
proposals. This is reassuring, as patients have an intimate
knowledge of the experience of suffering from particular
disorders, and so may well be able to shed useful light on
particular diagnostic criteria. Further editions of DSM
should continue to encourage feedback from the public,
and scientific experts should continue to pay close
attention to this valuable input as they develop their
recommendations.
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